US 11098053
Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells
granted A61KA61K31/352A61K35/28
Quick answer
US patent 11098053 (Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary of Agriculture
- Grant date
- Tue Aug 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/352, A61K35/28, A61K45/06, A61P